Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2011 Apr 1;52(7):953-6. doi: 10.1093/cid/cir029.

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.

Author information

  • 1MRC Clinical Trials Unit, London, United Kingdom. ajp@ctu.mrc.ac.uk


The impact of cotrimoxazole (CTX) on growth and/or anemia was investigated in 541 human immunodeficiency virus-infected, antiretroviral therapy-naive Zambian children enrolled in the Children with HIV Antibiotic Prophylaxis trial. Compared with children randomized to receive placebo, children randomized to receive CTX had slower decreases in weight-for-age (P=.04) and height-for-age (P=.01), and greater increase in hemoglobin level (P=.01). These findings argue for expanded early CTX use.

© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk